| abstract |
The present invention is based on the founding of a novel heterocyclic compound represented by general formula (I) (wherein the symbols are as defined in the description) or a pharmaceutically acceptable salt thereof, which serves as a compound that exhibits blood sugar level lowering action, blood lipid level lowering action and insulin resistance improving action by having PPARγ partial agonist action, PPARγ modulator action or PPARγ antagonistic action. A pharmaceutical product containing the compound is provided as a highly safe prophylactic and therapeutic agent for diabetes, metabolic syndrome and the like, said agent having few side effects. |